PE20211461A1 - Compuestos de heteroarilo sustituidos con alquilamida de piridinsulfona - Google Patents
Compuestos de heteroarilo sustituidos con alquilamida de piridinsulfonaInfo
- Publication number
- PE20211461A1 PE20211461A1 PE2020000703A PE2020000703A PE20211461A1 PE 20211461 A1 PE20211461 A1 PE 20211461A1 PE 2020000703 A PE2020000703 A PE 2020000703A PE 2020000703 A PE2020000703 A PE 2020000703A PE 20211461 A1 PE20211461 A1 PE 20211461A1
- Authority
- PE
- Peru
- Prior art keywords
- substituted
- alkyl
- pyridinsulfone
- alkylamide
- heteroaryl compounds
- Prior art date
Links
- 150000001875 compounds Chemical group 0.000 title abstract 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- BDGMPXXWWCGWLG-FIBGUPNXSA-N 6-(cyclopropanecarbonylamino)-4-[(3-methylsulfonylpyridin-2-yl)amino]-N-(trideuteriomethyl)pyridazine-3-carboxamide Chemical compound C1(CC1)C(=O)NC1=CC(=C(N=N1)C(=O)NC([2H])([2H])[2H])NC1=NC=CC=C1S(=O)(=O)C BDGMPXXWWCGWLG-FIBGUPNXSA-N 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000011234 negative regulation of signal transduction Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Referido a un compuesto de formula I, en donde Y es N o CR6; R1 es H, CD3 o C1-3 alquilo; R2 es -C(O)R2a; o C1-6 alquilo, -(CH2)r-carbociclo de 3-14 miembros sustituido con 0-1 R2a, entre otros; R4 y R5 son independientemente hidrogeno, C1-4 alquilo sustituido con 0-1 Rf, (CH2)r-fenilo sustituido con 0-3 Rd, entre otros. Un compuesto seleccionado es 6-ciclopropanamido-4-[(3-metansulfonilpiridin-2-il)amino]-N-(2H3)metilpiridazin-3-carboxamida. Estos compuestos de heterarilo sustituidos modulan IL-12, IL-23 y/o IFNalfa que actuan en Tyk-2 para generar la inhibicion de la transduccion de senal. Tambien se refiere a procedimiento para su elaboracion y compuestos intermediarios de los mismo, composicion farmaceutica, y su uso en el tratamiento de afecciones relacionadas con la modulacion de IL-12, IL-23 y/o IFNalfa.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762589165P | 2017-11-21 | 2017-11-21 | |
| PCT/US2018/061726 WO2019103952A1 (en) | 2017-11-21 | 2018-11-19 | Sulfone pyridine alkyl amide-substituted heteroaryl compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20211461A1 true PE20211461A1 (es) | 2021-08-05 |
Family
ID=65036887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2020000703A PE20211461A1 (es) | 2017-11-21 | 2018-11-19 | Compuestos de heteroarilo sustituidos con alquilamida de piridinsulfona |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US11021462B2 (es) |
| EP (1) | EP3713930A1 (es) |
| JP (2) | JP7258903B2 (es) |
| KR (1) | KR20200089706A (es) |
| CN (1) | CN111315737A (es) |
| AR (1) | AR113895A1 (es) |
| AU (3) | AU2018371010B2 (es) |
| BR (1) | BR112020009606A2 (es) |
| CA (1) | CA3083122A1 (es) |
| CL (1) | CL2020001338A1 (es) |
| CO (1) | CO2020006139A2 (es) |
| EA (1) | EA202091269A1 (es) |
| IL (1) | IL274816B2 (es) |
| MX (1) | MX2020005210A (es) |
| PE (1) | PE20211461A1 (es) |
| SG (1) | SG11202004592TA (es) |
| TW (1) | TWI776994B (es) |
| WO (1) | WO2019103952A1 (es) |
| ZA (1) | ZA202003717B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202004592TA (en) * | 2017-11-21 | 2020-06-29 | Bristol Myers Squibb Co | Sulfone pyridine alkyl amide-substituted heteroaryl compounds |
| CN111484480B (zh) * | 2019-01-29 | 2023-08-11 | 上海翰森生物医药科技有限公司 | 一种多环类衍生物抑制剂、其制备方法和应用 |
| US20220281842A1 (en) * | 2019-08-01 | 2022-09-08 | Integral Biosciences Pvt. Ltd. | Heterocyclic compounds as kinase inhibitor and uses thereof |
| WO2022135430A1 (en) * | 2020-12-22 | 2022-06-30 | InventisBio Co., Ltd. | Heteroaryl compounds, preparation methods and uses thereof |
| CA3208361A1 (en) | 2021-02-19 | 2022-08-25 | Anjali Pandey | Tyk2 inhibitors and uses thereof |
| WO2022206705A1 (zh) * | 2021-03-30 | 2022-10-06 | 浙江文达医药科技有限公司 | 作为tyk2假激酶结构域抑制剂的杂环化合物及合成方法和用途 |
| JP2024518792A (ja) * | 2021-05-14 | 2024-05-02 | ブリストル－マイヤーズ スクイブ カンパニー | 置換ヘテロ環化合物 |
| CN116693449A (zh) * | 2022-03-04 | 2023-09-05 | 上海致根医药科技有限公司 | 用作tyk2抑制剂的化合物、其制备方法及其在医药上的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR089682A1 (es) * | 2012-01-10 | 2014-09-10 | Hoffmann La Roche | Compuestos de piridazina-amida |
| JP2015534959A (ja) | 2012-10-19 | 2015-12-07 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | Ｓｙｋの阻害剤 |
| KR102233252B1 (ko) | 2012-11-08 | 2021-03-26 | 브리스톨-마이어스 스큅 컴퍼니 | ＩＬ-12, ＩＬ-23 및/또는 ＩＦＮα 반응의 조절제로서 유용한 알킬-아미드-치환된 피리딜 화합물 |
| MY175448A (en) | 2012-11-08 | 2020-06-29 | Bristol Myers Squibb Co | Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifna responses |
| TWI582077B (zh) | 2013-11-07 | 2017-05-11 | 必治妥美雅史谷比公司 | 作爲ＩＬ－１２、ＩＬ－２３及／或ＩＦＮα反應調節劑之經烷基－醯胺取代之吡啶化合物 |
| KR20160093675A (ko) | 2013-12-05 | 2016-08-08 | 파마싸이클릭스 엘엘씨 | 브루톤 티로신 키나제의 억제제 |
| MA48602A (fr) | 2016-12-13 | 2020-03-18 | Bristol Myers Squibb Co | Composés hétéroaryle substitués par un amide alkyle d'oxyde de phosphine en tant que modulateurs des réponses il-12, il-23 et/ou ifn alpha |
| SG11202004592TA (en) * | 2017-11-21 | 2020-06-29 | Bristol Myers Squibb Co | Sulfone pyridine alkyl amide-substituted heteroaryl compounds |
-
2018
- 2018-11-19 SG SG11202004592TA patent/SG11202004592TA/en unknown
- 2018-11-19 BR BR112020009606-7A patent/BR112020009606A2/pt unknown
- 2018-11-19 JP JP2020545054A patent/JP7258903B2/ja active Active
- 2018-11-19 WO PCT/US2018/061726 patent/WO2019103952A1/en unknown
- 2018-11-19 MX MX2020005210A patent/MX2020005210A/es unknown
- 2018-11-19 CN CN201880072389.7A patent/CN111315737A/zh active Pending
- 2018-11-19 CA CA3083122A patent/CA3083122A1/en active Pending
- 2018-11-19 PE PE2020000703A patent/PE20211461A1/es unknown
- 2018-11-19 IL IL274816A patent/IL274816B2/en unknown
- 2018-11-19 EA EA202091269A patent/EA202091269A1/ru unknown
- 2018-11-19 AU AU2018371010A patent/AU2018371010B2/en active Active
- 2018-11-19 EP EP18836556.3A patent/EP3713930A1/en active Pending
- 2018-11-19 KR KR1020207017459A patent/KR20200089706A/ko not_active Application Discontinuation
- 2018-11-20 TW TW107141159A patent/TWI776994B/zh active
- 2018-11-20 US US16/195,951 patent/US11021462B2/en active Active
- 2018-11-20 AR ARP180103395A patent/AR113895A1/es unknown
-
2020
- 2020-05-19 CO CONC2020/0006139A patent/CO2020006139A2/es unknown
- 2020-05-20 CL CL2020001338A patent/CL2020001338A1/es unknown
- 2020-06-19 ZA ZA2020/03717A patent/ZA202003717B/en unknown
-
2021
- 2021-04-28 US US17/242,428 patent/US11787779B2/en active Active
-
2022
- 2022-09-06 AU AU2022228101A patent/AU2022228101B2/en active Active
-
2023
- 2023-04-05 JP JP2023061359A patent/JP7490107B2/ja active Active
- 2023-09-05 US US18/461,093 patent/US20240002364A1/en active Pending
- 2023-10-27 AU AU2023255024A patent/AU2023255024A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3083122A1 (en) | 2019-05-31 |
| US20240002364A1 (en) | 2024-01-04 |
| TW201925187A (zh) | 2019-07-01 |
| AU2022228101B2 (en) | 2023-08-03 |
| IL274816B1 (en) | 2023-08-01 |
| AU2022228101A1 (en) | 2022-09-29 |
| JP2023098942A (ja) | 2023-07-11 |
| MX2020005210A (es) | 2020-08-20 |
| ZA202003717B (en) | 2022-01-26 |
| AR113895A1 (es) | 2020-06-24 |
| CL2020001338A1 (es) | 2020-09-25 |
| EA202091269A1 (ru) | 2020-08-07 |
| SG11202004592TA (en) | 2020-06-29 |
| EP3713930A1 (en) | 2020-09-30 |
| AU2018371010B2 (en) | 2022-06-09 |
| US11787779B2 (en) | 2023-10-17 |
| JP7490107B2 (ja) | 2024-05-24 |
| JP2021504443A (ja) | 2021-02-15 |
| WO2019103952A1 (en) | 2019-05-31 |
| KR20200089706A (ko) | 2020-07-27 |
| IL274816A (en) | 2020-07-30 |
| IL274816B2 (en) | 2023-12-01 |
| CN111315737A (zh) | 2020-06-19 |
| US11021462B2 (en) | 2021-06-01 |
| TWI776994B (zh) | 2022-09-11 |
| AU2018371010A1 (en) | 2020-07-02 |
| AU2023255024A1 (en) | 2023-11-16 |
| US20190152948A1 (en) | 2019-05-23 |
| JP7258903B2 (ja) | 2023-04-17 |
| BR112020009606A2 (pt) | 2020-11-03 |
| CO2020006139A2 (es) | 2020-05-29 |
| US20210253554A1 (en) | 2021-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20211461A1 (es) | Compuestos de heteroarilo sustituidos con alquilamida de piridinsulfona | |
| EA201992253A1 (ru) | Новые гетероциклические производные, применимые в качестве ингибиторов shp2 | |
| EA202092003A1 (ru) | Соединения для лечения болезни гентингтона | |
| EA202092896A1 (ru) | Гетероциклические и гетероарильные соединения для лечения болезни гентингтона | |
| EA202092899A1 (ru) | Гетероарильные соединения для лечения болезни гентингтона | |
| CO2018005848A2 (es) | Compuestos de pirazol o sus sales, métodos de preparación de los mismos, composiciones herbicidas y su uso | |
| UY37513A (es) | Modulador del regulador de conductancia transmembrana de fibrosis quística, composiciones farmacéuticas, métodos de tratamiento y proceso para producir el modulador | |
| EA202191142A1 (ru) | Амидзамещенные гетероциклические соединения | |
| EA201791584A1 (ru) | Агрохимическая композиция | |
| RU2020124113A (ru) | Фунгицидные оксадиазолы | |
| CU24448B1 (es) | Compuestos de indazol sustituidos y compuestos intermediarios para la preparación de los mismos | |
| AR077818A1 (es) | Composiciones pesticidas | |
| CL2014003181A1 (es) | Compuestos derivados de benzamidas n- sustituidas o piridinamidas n-sustituidas; composicion farmaceutica que los comprende; metodo de tratamiento; y su uso para el tratamiento de enfermedades o trastornos seleccionados de dolor, depresion y enfermedades cardiovasculares, respiratorias o psiquiatricas o combinaciones de estas. | |
| PE20151981A1 (es) | Pontenciador de inhibidores del homologo de zeste | |
| AR068055A1 (es) | Derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol su procedimiento de preparacion su aplicacion como medicamentos composiciones farmaceuticas y su utilizacion principalmente como inhibidores de met | |
| AR082241A1 (es) | COMPUESTOS PARA REDUCIR LA PRODUCCION DE AMILOIDE b | |
| EA202092263A1 (ru) | Аминопиридиновые производные в качестве ингибиторов ctps1 | |
| UY29070A1 (es) | Enantiómeros de heterocíclicos fusionados y sus usos | |
| MX2020008265A (es) | Derivados farmaceuticos del anillo heterobiciclico 6,5. | |
| AR061973A1 (es) | Compuesto de 2-arilindol sustituido en la posicion 5, composicion farmaceutica que lo comprende, compuestos intermedios y procedimiento para la preparacion de los mismos | |
| AR087302A1 (es) | Derivados aza heterociclicos sustituidos | |
| EA202190055A1 (ru) | Производные пиразола в качестве ингибиторов malt1 | |
| EA201891379A1 (ru) | Ингибиторы тирозинкиназы брутона и способы их применения | |
| BR112018001816A2 (pt) | “análogos de adamantil ureias como inibidores solúveis da epóxido hidrolase | |
| EA202090980A1 (ru) | Синтез антибактериальных аминогликозидных аналогов |